18758815

Source:http://linkedlifedata.com/resource/pubmed/id/18758815

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0079731, umls-concept:C0580822, umls-concept:C1521750, umls-concept:C1547300, umls-concept:C1548760, umls-concept:C1550594, umls-concept:C1705294
pubmed:issue	3
pubmed:dateCreated	2009-2-2
pubmed:abstractText	Anthracyline-based chemotherapy is the treatment of choice for patients with aggressive B-cell non-Hodgkin's lymphoma (NHL). However, anthracyclines have been associated with long-term cardiac toxicity.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7902060
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anthracyclines, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal..., http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating..., http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine, http://linkedlifedata.com/resource/pubmed/chemical/rituximab
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1432-1335
pubmed:author	pubmed-author:AnhufJJ, pubmed-author:DerksCC, pubmed-author:EbelingPP, pubmed-author:HenseJJ, pubmed-author:MetzKK, pubmed-author:MoritaMM, pubmed-author:NeiseMM, pubmed-author:NiederleNN, pubmed-author:NowrousianMohammad RMR, pubmed-author:PoseyDD, pubmed-author:SandmannMM, pubmed-author:SchüttPP, pubmed-author:SeeberSS, pubmed-author:StuschkeMM, pubmed-author:WelzKK, pubmed-author:ZimmermannKK
pubmed:issnType	Electronic
pubmed:volume	135
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	459-66
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:18758815-Adolescent, pubmed-meshheading:18758815-Adult, pubmed-meshheading:18758815-Anthracyclines, pubmed-meshheading:18758815-Antibodies, Monoclonal, pubmed-meshheading:18758815-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:18758815-Antineoplastic Agents, pubmed-meshheading:18758815-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18758815-Cyclophosphamide, pubmed-meshheading:18758815-Disease Progression, pubmed-meshheading:18758815-Disease-Free Survival, pubmed-meshheading:18758815-Dose-Response Relationship, Drug, pubmed-meshheading:18758815-Doxorubicin, pubmed-meshheading:18758815-Female, pubmed-meshheading:18758815-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:18758815-Humans, pubmed-meshheading:18758815-Lymphoma, B-Cell, pubmed-meshheading:18758815-Male, pubmed-meshheading:18758815-Middle Aged, pubmed-meshheading:18758815-Neoplasm Staging, pubmed-meshheading:18758815-Prednisone, pubmed-meshheading:18758815-Prognosis, pubmed-meshheading:18758815-Remission Induction, pubmed-meshheading:18758815-Survival Analysis, pubmed-meshheading:18758815-Survivors, pubmed-meshheading:18758815-Vincristine, pubmed-meshheading:18758815-Young Adult
pubmed:year	2009
pubmed:articleTitle	Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin's lymphoma.
pubmed:affiliation	Department of Internal Medicine (Cancer Research), West German Cancer Center, University of Duisburg-Essen Medical School, Hufelandstrasse 55, 45122, Essen, Germany.
pubmed:publicationType	Journal Article, Multicenter Study, Clinical Trial, Phase II